May 9, 2022 General information Neurodevelopmental study shines some noise on why teens tune out mom’s voice and pay more attention to others.
April 26, 2022 Neurology Phase 2 study demonstrates that a new blood plasma Alzheimer biomarker may assist in earlier diagnosis of Alzheimer’s disease
April 8, 2022 Apps and diagnosis Study tries to elucidate if instant-gratification apps like TikTok have a negative impact on a child’s attention-span development.
March 10, 2022 Emergency Medicine CHEO study reports on risks of increased mental health issues in children after concussion.
March 9, 2022 Infectious Disease Mild Covid is associated with comparative imaging scans showing pathological changes in brain structure in people age 51-81 taken from UK Biobank data
January 14, 2022 Clinical Research New evidence strongly suggests Epstein-Barr virus (EBV) may help trigger Multiple Sclerosis. Opens the door to further investigation of the mechanism of the disease and if corroborated, lead to vaccines to prevent EBV infection.
July 30, 2021 Neurology Researchers report concerns about dementia following COVID-19 infection but the data is incomplete and much greater numbers of well-conducted studies need to be done to determine if there is a causal link.
June 22, 2021 Clinical Research Preprint longitudinal controlled MRI-imaging study notes direct evidence of brain abnormalities in people who had COVID (matched and compared to those did not) that could explain the symptoms of Long-COVID. #LongHaulers #LongCovid #VaccinesWork
June 8, 2021 Health Policy FDA approval process questioned as it approves new early-stage $56K US/year treatment for Alzheimer’s despite its own panel founding insufficient evidence of efficacy. Only when company changed the study endpoint did it show efficacy compared to placebo.
